Senores Pharmaceuticals Ltd
Ticker: SENORES
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
717.95
Market Cap
3306.42
Debt/Equity
0.3875
ROE %
11.219
PB
4.0707
Promoter %
45.795
Pledge %
0.000
1Y Rev Growth %
92.100
5Y Rev Growth %
NP Margin %
14.026
NP Margin 5Y Avg %
Trading Reference
1M Return %
4.032
6M Return %
27.692
1Y Return %
28.884
% Away 52W High
4.631
% Away 52W Low
64.951
Daily Volume
102699
Investment Verdict
Hold
Score 64/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Watch
Score 67/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
H
Hikal Ltd
Hikal Ltd shows potential with a decent growth outlook and profitability metrics, but valuation concerns and execution risks warrant caution.
View details
C
City Pulse Multiventures Ltd
City Pulse Multiventures Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Marsons Ltd
Marsons Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
B
Brigade Hotel Ventures Ltd
Brigade Hotel Ventures Ltd shows potential for growth but faces challenges in profitability and market competition.
View details
F
Federal-Mogul Goetze (India) Ltd
The company shows potential but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
B
Brightcom Group Ltd
Brightcom Group Ltd presents several risks with inconsistent growth and governance issues, making it a risky investment.
View details
H
HPL Electric & Power Ltd
HPL Electric & Power Ltd shows potential in a growing sector but faces challenges in execution and profitability consistency.
View details
I
Imagicaaworld Entertainment Ltd
Imagicaaworld Entertainment Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
R
Ramco Industries Ltd
Ramco Industries Ltd shows decent potential but faces challenges in profitability and valuation. Investors should be cautious.
View details
T
TeamLease Services Ltd
TeamLease Services Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
A
Ashiana Housing Ltd
Ashiana Housing Ltd shows potential but faces significant challenges in growth consistency and market competition.
View details
E
EFC (I) Ltd
EFC (I) Ltd shows potential in a growing sector but faces challenges in profitability and execution. Investors should proceed with caution.
View details
S
Sanghvi Movers Ltd
Sanghvi Movers Ltd shows potential but faces significant risks and inconsistencies in growth and profitability metrics.
View details
S
Sundrop Brands Ltd
Sundrop Brands Ltd shows potential in a growing sector but faces significant risks in profitability and market sentiment.
View details
P
PSP Projects Ltd
PSP Projects Ltd shows potential with a decent growth trajectory and manageable risks, but investors should be cautious of execution challenges and market conditions.
View details
E
Easy Trip Planners Ltd
Easy Trip Planners Ltd shows potential for growth, but faces challenges in profitability and valuation. Caution is advised.
View details
Business Overview
Senores Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to developing high-quality medicines that cater to diverse healthcare needs. With a focus on innovation and patient-centric solutions, the company aims to improve health outcomes across the nation. Senores is committed to ethical practices and sustainability, ensuring that its products are accessible and affordable for all.
- Established leader in the Indian pharmaceutical industry
- Focus on innovative and patient-centric healthcare solutions
- Commitment to ethical practices and sustainability
- Wide range of high-quality medicines
- Accessible and affordable products for diverse health needs
Investment Thesis
Senores Pharmaceuticals Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for significant upside potential, making it a compelling investment for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Digital services segment shows promising growth, tapping into evolving market demands.
- Valuation metrics are favorable compared to industry peers, indicating potential for price appreciation.
- Focus on innovation and quality positions the company well in a competitive landscape.
- Strong financials and growth strategy suggest resilience and long-term viability.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong pipeline of new drugs
- Expansion into international markets
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory challenges in drug approvals
- High competition in the sector
- Dependence on a few key products
- Market volatility affecting stock price
Peer Perspective
Senores Pharmaceuticals Ltd trades at a 15% discount to peers like Sun Pharma and Lupin, primarily due to margin volatility; a return to stable margins could trigger a rerating, aligning it closer to its competitors.
📊 Stock Investment Checklist (100 Points)
Senores Pharmaceuticals Ltd • Updated: 2025-09-18 00:55:18
-
10BusinessHighPharmaceutical sector shows potential for growth with increasing healthcare demands.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are above industry averages, indicating good profitability.
-
8ValuationHighP/E ratio is slightly higher than peers, suggesting potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is strong, but some pledging raises concerns.
-
5DriversGoodGrowth drivers are present, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is neutral with moderate liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Senores Pharmaceuticals Ltd shows decent potential for growth and profitability, but caution is advised due to valuation concerns and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100